Product Description
Alkixen 250 mg (Crizotinib)
Alkixen 250 mg (Crizotinib) is a specialized oral chemotherapy medication used in the targeted treatment of certain types of advanced lung cancer. As a precision oncology drug, it is designed to inhibit specific proteins that drive the growth of cancer cells.
This medication is manufactured by Everest Pharmaceuticals Ltd., a leading pharmaceutical manufacturer in Bangladesh, and is supplied globally by Mediaid Pharmacy. We are a trusted partner in ensuring patients and healthcare providers worldwide have access to genuine, high-quality oncology treatments.
What is Alkixen 250 mg (Crizotinib)?
Alkixen contains the active ingredient Crizotinib, which belongs to a class of drugs known as tyrosine kinase inhibitors (TKIs). It works by targeting and blocking the activity of specific abnormal proteins—specifically Anaplastic Lymphoma Kinase (ALK) and ROS1.
In patients with these specific genetic mutations, these proteins are overactive and signal cancer cells to grow and divide. By inhibiting these kinases, Alkixen effectively slows down or stops the growth and spread of the tumor.
Indications for Use
Alkixen 250 mg is indicated for the treatment of patients with metastatic Non-Small Cell Lung Cancer (NSCLC) whose tumors have specific genetic features:
- ALK-positive NSCLC: For the treatment of patients with metastatic non-small cell lung cancer whose tumors are anaplastic lymphoma kinase (ALK)-positive.
- ROS1-positive NSCLC: For the treatment of patients with metastatic non-small cell lung cancer whose tumors are ROS1-positive.
The presence of these mutations must be confirmed by an FDA-approved test or a validated laboratory test before starting treatment.
Dosage & Administration
The standard recommended dosage of Alkixen is 250 mg taken orally twice daily (every 12 hours). It can be taken with or without food.
- Capsules should be swallowed whole. Do not crush, dissolve, or open the capsule.
- If a dose is missed, it can be taken as soon as remembered unless the next dose is due within 6 hours.
- Always follow the specific dosage instructions provided by your qualified oncologist.
Manufacturer – Everest Pharmaceuticals Ltd.
Everest Pharmaceuticals Ltd. is a rapidly growing pharmaceutical company in Bangladesh, renowned for its dedication to producing high-quality oncology medications. With state-of-the-art manufacturing facilities that adhere to strict international Good Manufacturing Practices (GMP), Everest ensures that products like Alkixen meet rigorous global safety and efficacy standards.
Supplier – Mediaid Pharmacy
Mediaid Pharmacy is your reliable global supplier and distributor of specialized medicines, including Alkixen 250 mg. We are committed to making advanced cancer care accessible to patients around the world.
Mediaid Pharmacy is known for:
- Worldwide Shipping: We securely ship medications to patients, pharmacies, and hospitals in countries across the globe.
- Guaranteed Authenticity: We source Alkixen 250 mg directly from Everest Pharmaceuticals to ensure you receive 100% genuine products.
- Patient-Centric Service: Our professional team offers expert support and ensures a seamless, confidential ordering process.
- Competitive Pricing: We aim to provide the most affordable prices for essential oncology treatments.
Why Choose Alkixen 250 mg from Mediaid Pharmacy?
- Dual Action: Effective for both ALK-positive and ROS1-positive lung cancers.
- Proven Effectiveness: Clinically shown to shrink tumors and slow disease progression in patients with these mutations.
- High-Quality Manufacturing: Produced by Everest Pharmaceuticals under strict quality control.
- Global Availability: Distributed efficiently by Mediaid Pharmacy with reliable shipping options.
Frequently Asked Questions (FAQs)
Q: How do I know if Alkixen is right for me?
A: Alkixen is only effective for patients with ALK-positive or ROS1-positive NSCLC. Your oncologist will perform a genetic test on your tumor to confirm if you have these mutations.
Q: How is Alkixen packaged?
A: Alkixen 250 mg is available in a box containing 60 capsules.
Q: Can I drink grapefruit juice while taking this medication?
A: Patients are generally advised to avoid grapefruit or grapefruit juice while taking Crizotinib, as it may increase the amount of the drug in your blood.
Conclusion
Alkixen 250 mg (Crizotinib) offers a targeted and effective treatment option for patients battling ALK-positive or ROS1-positive non-small cell lung cancer. Manufactured by Everest Pharmaceuticals and supplied by Mediaid Pharmacy, this medication provides a beacon of hope through precision medicine.
Contact Us to Order or Inquire
For the latest pricing, bulk orders, or to speak with our pharmacy team about Alkixen 250 mg (Crizotinib), please contact us. We are available 24/7 to support your healthcare needs.
WhatsApp/WeChat: +8801773428128






